Pfizer (NYSE:PFE) reported its Q1 earnings results on Tuesday, May 3, 2022 at 06:45 AM.
Here's what investors need to know about the announcement.
Earnings
Pfizer beat estimated earnings by 8.0%, reporting an EPS of $1.62 versus an estimate of $1.5.
Revenue was up $11.08 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.21 which was followed by a 0.44% drop in the share price the next day.
Here's a look at Pfizer's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | 0.87 | 1.09 | 0.96 | 0.78 |
EPS Actual | 1.08 | 1.34 | 1.07 | 0.93 |
Revenue Estimate | 24.20B | 22.71B | 18.45B | 13.60B |
Revenue Actual | 23.84B | 24.09B | 18.98B | 14.58B |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Pfizer management provided guidance for FY 2022, expecting earnings between $6.25 and $6.45 per share.
To track all earnings releases for Pfizer visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.